Programs

The Regulatory Science Lab is an innovative program of research focused on the sustainability, value and social impacts of precision medicine. Our research initiatives identify community-defined risks and benefits of precision medicine, its cost-effectiveness, and what policy changes can support the responsible and equitable application of multi-omics. Our research studies estimate preference-based utility and acceptability of multi-omic technologies, as well as include value for money assessments.

A 2024 BC Cancer Emerging Multidisciplinary Research Program made possible through a BC Government grant to the BC Cancer Foundation to support enhancements to research.

Brain cancers are among the most deadly and debilitating forms of cancer in adults and children. This is especially true for high-grade gliomas (HGG) where fewer than 1 in 20 patients survive 5 years after diagnosis.

Acute leukemia remains a devastating disease, especially in adults, with survival rates below 50%. Even for children, where rates are higher, intense chemotherapy often leads to long-term health challenges. The urgency to understand the molecular intricacies of leukemia cells, particularly their differences from normal hematopoietic cells, is paramount.